Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium bicarbonate correction of metabolic acidosis and intrarenal RAS activity in chronic kidney disease
NL-OMON45074Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sodium bicarbonate and sodium chloride in chronic kidney disease (CKD) and metabolic acidosis (2 arms), sponsored by Erasmus MC. Primary endpoint: Change in urinary renin. Started Apr 2014; status: active, not recruiting.
02
Drugs
sodium bicarbonatesodium chloride
03
Conditions
chronic kidney disease (CKD)metabolic acidosis
Beyond the preview
Go deeper on NL-OMON45074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45074.